Vivos Stock Forecast for 2023 - 2025 - 2030
Updated on 05/20/2024
Vivos Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Vivos's Price has seen a drop from $36.00 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$543.45 | Buy/Sell | $583.92 | 7.28% |
| LNTH Stock Forecast | Lantheus Holdings | Buy |
14
|
$79.67 | Buy/Sell | $91.75 | 25.52% |
| TXG Stock Forecast | 10x Genomics | Outperform |
6
|
$25.01 | Buy/Sell | $58.14 | 61.94% |
| QDEL Stock Forecast | Quidel Corp | Hold |
16
|
$42.82 | Buy/Sell | $121.00 | 12.10% |
| IMMU Stock Forecast | Immunomedics | - |
2
|
$0.48 | Buy/Sell | $47.60 | -100.00% |
Vivos Revenue Forecast for 2023 - 2025 - 2030
Vivos's Revenue has seen growth In the last three years, going from $10000.00 to $20.00k – a gain of 100.00% In the next year, analysts believe that Revenue will reach $21.67k – an increase of 8.33%. For the next seven years, the forecast is forRevenue to grow by 30.42%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GH Stock Forecast | Guardant Health | Buy |
6
|
$25.36 | Buy/Sell | $43.00 | 51.81% |
| MYGN Stock Forecast | Myriad Genetics | Outperform |
6
|
$25.29 | Buy/Sell | $22.08 | -1.15% |
| LMNX Stock Forecast | Luminex | - |
12
|
$36.99 | Buy/Sell | $37.00 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VCYT Stock Forecast | Veracyte | Outperform |
11
|
$22.88 | Buy/Sell | $32.17 | 31.12% |
| VIVO Stock Forecast | Meridian Bioscience | - |
18
|
$0.03 | Buy/Sell | $34.00 | -100.00% |
| HSKA Stock Forecast | Heska | - |
12
|
$119.99 | Buy/Sell | $125.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CDNA Stock Forecast | CareDx, Inc | Outperform |
9
|
$15.50 | Buy/Sell | $11.80 | -6.45% |
| ADPT Stock Forecast | Adaptive Biotechnologies | Outperform |
6
|
$3.61 | Buy/Sell | $8.67 | 52.35% |
| CELC Stock Forecast | Celcuity | Buy |
9
|
$16.76 | Buy/Sell | $23.33 | 61.10% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CDMO Stock Forecast | Avid Bioservices | Outperform |
12
|
$9.12 | Buy/Sell | $18.50 | 42.54% |
| LXRX Stock Forecast | Lexicon Pharmaceuticals | Outperform |
6
|
$1.77 | Buy/Sell | $5.15 | 154.24% |
| OSUR Stock Forecast | OraSure Technologies | Hold |
11
|
$4.92 | Buy/Sell | $7.40 | 21.95% |
Vivos EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Vivos's EBIT has grown, increasing from $-670.00k to $-2.79M – an increase of 316.42%. 0 analysts predict Vivos's EBIT will decrease by 27.89% in the next year, reaching $-2.01M. By 2030, professionals predict that Vivos's EBIT will decrease by 16.70%, to $-2.32M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A950130 Stock Forecast | Access Bio | - |
7
|
₩7.43k | Buy/Sell | ₩8.40k | -100.00% |
| PSNL Stock Forecast | Personalis | Outperform |
6
|
$1.40 | Buy/Sell | $4.45 | 185.71% |
| VNRX Stock Forecast | VolitionRx | Outperform |
11
|
$0.77 | Buy/Sell | $3.76 | 412.99% |
Vivos EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Vivos's EPS has seen a drop from $2.40 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MYMD Stock Forecast | Akers Biosciences | - |
0
|
$4.24 | Buy/Sell | $0.00 | -100.00% |
| LUDG Stock Forecast | Ludwig Enterprises | - |
0
|
$0.22 | Buy/Sell | $0.00 | -100.00% |
| ICCC Stock Forecast | ImmuCell | - |
0
|
$4.81 | Buy/Sell | $14.00 | -100.00% |
.jpg)